Logo image of CLB

CORE LABORATORIES INC (CLB) Stock Fundamental Analysis

NYSE:CLB - New York Stock Exchange, Inc. - US21867A1051 - Common Stock - Currency: USD

17.24  +0.69 (+4.17%)

After market: 17.24 0 (0%)

Fundamental Rating

4

CLB gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 59 industry peers in the Energy Equipment & Services industry. Both the profitability and the financial health of CLB get a neutral evaluation. Nothing too spectacular is happening here. CLB does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

4

1. Profitability

1.1 Basic Checks

In the past year CLB was profitable.
In the past year CLB had a positive cash flow from operations.
In multiple years CLB reported negative net income over the last 5 years.
Of the past 5 years CLB 4 years had a positive operating cash flow.
CLB Yearly Net Income VS EBIT VS OCF VS FCFCLB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100M 200M

1.2 Ratios

CLB's Return On Assets of 6.26% is fine compared to the rest of the industry. CLB outperforms 63.79% of its industry peers.
CLB's Return On Equity of 16.32% is fine compared to the rest of the industry. CLB outperforms 72.41% of its industry peers.
CLB's Return On Invested Capital of 8.97% is fine compared to the rest of the industry. CLB outperforms 67.24% of its industry peers.
The Average Return On Invested Capital over the past 3 years for CLB is in line with the industry average of 8.35%.
The last Return On Invested Capital (8.97%) for CLB is above the 3 year average (7.69%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 6.26%
ROE 16.32%
ROIC 8.97%
ROA(3y)4.34%
ROA(5y)1.8%
ROE(3y)13.16%
ROE(5y)-7.94%
ROIC(3y)7.69%
ROIC(5y)8.82%
CLB Yearly ROA, ROE, ROICCLB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -100 -200 -300

1.3 Margins

CLB has a Profit Margin (7.20%) which is in line with its industry peers.
In the last couple of years the Profit Margin of CLB has declined.
With a decent Operating Margin value of 11.27%, CLB is doing good in the industry, outperforming 62.07% of the companies in the same industry.
In the last couple of years the Operating Margin of CLB has declined.
Looking at the Gross Margin, with a value of 21.54%, CLB is doing worse than 62.07% of the companies in the same industry.
In the last couple of years the Gross Margin of CLB has declined.
Industry RankSector Rank
OM 11.27%
PM (TTM) 7.2%
GM 21.54%
OM growth 3Y-2.8%
OM growth 5Y-8.16%
PM growth 3YN/A
PM growth 5Y-8.71%
GM growth 3Y-2.28%
GM growth 5Y-5.83%
CLB Yearly Profit, Operating, Gross MarginsCLB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10 -10 20 -20 30

More info and screens

5

2. Health

2.1 Basic Checks

CLB has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
CLB has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
CLB Yearly Shares OutstandingCLB Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M
CLB Yearly Total Debt VS Total AssetsCLB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M

2.2 Solvency

An Altman-Z score of 3.10 indicates that CLB is not in any danger for bankruptcy at the moment.
With a decent Altman-Z score value of 3.10, CLB is doing good in the industry, outperforming 79.31% of the companies in the same industry.
CLB has a debt to FCF ratio of 11.48. This is a negative value and a sign of low solvency as CLB would need 11.48 years to pay back of all of its debts.
With a Debt to FCF ratio value of 11.48, CLB perfoms like the industry average, outperforming 43.10% of the companies in the same industry.
A Debt/Equity ratio of 0.73 indicates that CLB is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.73, CLB is not doing good in the industry: 74.14% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.73
Debt/FCF 11.48
Altman-Z 3.1
ROIC/WACC1.02
WACC8.79%
CLB Yearly LT Debt VS Equity VS FCFCLB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100M 200M 300M 400M

2.3 Liquidity

A Current Ratio of 2.53 indicates that CLB has no problem at all paying its short term obligations.
With a decent Current ratio value of 2.53, CLB is doing good in the industry, outperforming 74.14% of the companies in the same industry.
CLB has a Quick Ratio of 1.72. This is a normal value and indicates that CLB is financially healthy and should not expect problems in meeting its short term obligations.
CLB's Quick ratio of 1.72 is fine compared to the rest of the industry. CLB outperforms 68.97% of its industry peers.
Industry RankSector Rank
Current Ratio 2.53
Quick Ratio 1.72
CLB Yearly Current Assets VS Current LiabilitesCLB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M

More info and screens

3

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 3.66% over the past year.
CLB shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -14.36% yearly.
EPS 1Y (TTM)3.66%
EPS 3Y4.92%
EPS 5Y-14.36%
EPS Q2Q%13.64%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%7.22%

3.2 Future

CLB is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 14.39% yearly.
CLB is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.47% yearly.
EPS Next Y19.72%
EPS Next 2Y14.69%
EPS Next 3Y11.65%
EPS Next 5Y14.39%
Revenue Next Year5.21%
Revenue Next 2Y3.73%
Revenue Next 3Y4.01%
Revenue Next 5Y3.47%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
CLB Yearly Revenue VS EstimatesCLB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 200M 400M 600M 800M 1B
CLB Yearly EPS VS EstimatesCLB Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 1 2 3 4 5

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 20.28, CLB is valued on the expensive side.
Compared to the rest of the industry, the Price/Earnings ratio of CLB indicates a somewhat cheap valuation: CLB is cheaper than 60.34% of the companies listed in the same industry.
CLB is valuated rather cheaply when we compare the Price/Earnings ratio to 28.47, which is the current average of the S&P500 Index.
CLB is valuated rather expensively with a Price/Forward Earnings ratio of 17.56.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CLB is on the same level as its industry peers.
The average S&P500 Price/Forward Earnings ratio is at 92.74. CLB is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 20.28
Fwd PE 17.56
CLB Price Earnings VS Forward Price EarningsCLB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

CLB's Enterprise Value to EBITDA ratio is rather expensive when compared to the industry. CLB is more expensive than 84.48% of the companies in the same industry.
CLB's Price/Free Cash Flow ratio is a bit more expensive when compared to the industry. CLB is more expensive than 62.07% of the companies in the same industry.
Industry RankSector Rank
P/FCF 56.96
EV/EBITDA 13.07
CLB Per share dataCLB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

CLB's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
PEG (NY)1.03
PEG (5Y)N/A
EPS Next 2Y14.69%
EPS Next 3Y11.65%

More info and screens

3

5. Dividend

5.1 Amount

With a yearly dividend of 0.23%, CLB is not a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 3.38, CLB has a dividend in line with its industry peers.
Compared to an average S&P500 Dividend Yield of 2.28, CLB's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.23%

5.2 History

The dividend of CLB decreases each year by -73.70%.
CLB has paid a dividend for at least 10 years, which is a reliable track record.
CLB has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)-73.7%
Div Incr Years0
Div Non Decr Years3
CLB Yearly Dividends per shareCLB Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5 2

5.3 Sustainability

5.09% of the earnings are spent on dividend by CLB. This is a low number and sustainable payout ratio.
DP5.09%
EPS Next 2Y14.69%
EPS Next 3Y11.65%
CLB Yearly Income VS Free CF VS DividendCLB Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50M -50M 100M 150M
CLB Dividend Payout.CLB Dividend Payout, showing the Payout Ratio.CLB Dividend Payout.PayoutRetained Earnings

More info and screens

CORE LABORATORIES INC

NYSE:CLB (2/4/2025, 8:04:00 PM)

After market: 17.24 0 (0%)

17.24

+0.69 (+4.17%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryEnergy Equipment & Services
Earnings (Last)10-23 2024-10-23/amc
Earnings (Next)N/A N/A
Inst Owners113.32%
Inst Owner Change0.26%
Ins Owners0.88%
Ins Owner Change3.49%
Market Cap809.42M
Analysts46.67
Price Target19.38 (12.41%)
Short Float %13.31%
Short Ratio20.77
Dividend
Industry RankSector Rank
Dividend Yield 0.23%
Yearly Dividend0.04
Dividend Growth(5Y)-73.7%
DP5.09%
Div Incr Years0
Div Non Decr Years3
Ex-Date02-10 2025-02-10 (0.01)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-1.67%
Min EPS beat(2)-2.24%
Max EPS beat(2)-1.1%
EPS beat(4)2
Avg EPS beat(4)4.99%
Min EPS beat(4)-2.24%
Max EPS beat(4)19.06%
EPS beat(8)4
Avg EPS beat(8)1.86%
EPS beat(12)5
Avg EPS beat(12)1.29%
EPS beat(16)8
Avg EPS beat(16)4.46%
Revenue beat(2)0
Avg Revenue beat(2)-2.58%
Min Revenue beat(2)-4.52%
Max Revenue beat(2)-0.65%
Revenue beat(4)1
Avg Revenue beat(4)-1.98%
Min Revenue beat(4)-4.52%
Max Revenue beat(4)0.92%
Revenue beat(8)1
Avg Revenue beat(8)-1.86%
Revenue beat(12)2
Avg Revenue beat(12)-1.91%
Revenue beat(16)3
Avg Revenue beat(16)-1.75%
PT rev (1m)0%
PT rev (3m)-5%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)1.85%
EPS NY rev (3m)0.88%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)-0.14%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 20.28
Fwd PE 17.56
P/S 1.59
P/FCF 56.96
P/OCF 32.65
P/B 3.6
P/tB 6.83
EV/EBITDA 13.07
EPS(TTM)0.85
EY4.93%
EPS(NY)0.98
Fwd EY5.69%
FCF(TTM)0.3
FCFY1.76%
OCF(TTM)0.53
OCFY3.06%
SpS10.86
BVpS4.79
TBVpS2.52
PEG (NY)1.03
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 6.26%
ROE 16.32%
ROCE 11.53%
ROIC 8.97%
ROICexc 9.25%
ROICexgc 11.86%
OM 11.27%
PM (TTM) 7.2%
GM 21.54%
FCFM 2.79%
ROA(3y)4.34%
ROA(5y)1.8%
ROE(3y)13.16%
ROE(5y)-7.94%
ROIC(3y)7.69%
ROIC(5y)8.82%
ROICexc(3y)7.95%
ROICexc(5y)9.08%
ROICexgc(3y)10.28%
ROICexgc(5y)12.34%
ROCE(3y)9.9%
ROCE(5y)11.35%
ROICexcg growth 3Y-3.08%
ROICexcg growth 5Y-17.63%
ROICexc growth 3Y-2.58%
ROICexc growth 5Y-12.11%
OM growth 3Y-2.8%
OM growth 5Y-8.16%
PM growth 3YN/A
PM growth 5Y-8.71%
GM growth 3Y-2.28%
GM growth 5Y-5.83%
F-Score8
Asset Turnover0.87
Health
Industry RankSector Rank
Debt/Equity 0.73
Debt/FCF 11.48
Debt/EBITDA 2.23
Cap/Depr 67.02%
Cap/Sales 2.08%
Interest Coverage 5.13
Cash Conversion 33.85%
Profit Quality 38.72%
Current Ratio 2.53
Quick Ratio 1.72
Altman-Z 3.1
F-Score8
WACC8.79%
ROIC/WACC1.02
Cap/Depr(3y)66.43%
Cap/Depr(5y)70.98%
Cap/Sales(3y)2.34%
Cap/Sales(5y)2.56%
Profit Quality(3y)77.3%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)3.66%
EPS 3Y4.92%
EPS 5Y-14.36%
EPS Q2Q%13.64%
EPS Next Y19.72%
EPS Next 2Y14.69%
EPS Next 3Y11.65%
EPS Next 5Y14.39%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%7.22%
Revenue Next Year5.21%
Revenue Next 2Y3.73%
Revenue Next 3Y4.01%
Revenue Next 5Y3.47%
EBIT growth 1Y30.29%
EBIT growth 3Y-1.32%
EBIT growth 5Y-13.83%
EBIT Next Year38.5%
EBIT Next 3Y18.14%
EBIT Next 5Y17.08%
FCF growth 1Y-3.99%
FCF growth 3Y-32.4%
FCF growth 5Y-30.7%
OCF growth 1Y-0.84%
OCF growth 3Y-24.63%
OCF growth 5Y-26.01%